Publications

Show Filters

Searches all publications.

Search Fulltext

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-06-24
    E.g., 2018-06-24

Articles

Pages

79362 items
12:19 PM, Jun 22, 2018  |  BC Week In Review | Company News  |  Other News

Daewoong restructuring R&D

Daewoong Pharmaceutical Co. Ltd. (KSE:069620) said it is restructuring its R&D group. The company said the goal is to "expedite new drug development" and to strengthen three newly announced centers. The three centers will focus on...
12:19 PM, Jun 22, 2018  |  BC Week In Review | Company News  |  Deals

AHA, ADA partner with industry to launch diabetes, cardiovascular disease initiative

The American Heart Association and American Diabetes Association partnered with Boehringer Ingelheim GmbH (Ingelheim, Germany), Eli Lilly and Co. (NYSE:LLY) and Novo Nordisk A/S (CSE:NOVO B; NYSE:NVO) to launch a 3.5 year initiative to help...
12:15 PM, Jun 22, 2018  |  BC Week In Review | Company News  |  Deals

UCSD launches bacteriophage treatment center

The University of California San Diego launched the Center for Innovative Phage Applications and Therapeutics (IPATH) to develop bacteriophages to fight multidrug-resistant bacteria. The initial focus will be on treating chronic infections associated with cystic...
12:14 PM, Jun 22, 2018  |  BC Week In Review | Company News  |  Deals

J&J opens JLABS incubator in NYC

The Johnson & Johnson Innovation LLC subsidiary of Johnson & Johnson (NYSE:JNJ) opened JLABS@NYC, a JLABS incubator in New York City, with 26 resident companies. Resident companies at JLABS include the four winners of the JLABS@NYC...
11:09 AM, Jun 22, 2018  |  BC Week In Review | Company News  |  Other News

UC Regents get CRISPR guide RNA patent in U.S.

The U.S. Patent Office on June 19 granted a patent related to CRISPR-Cas9 gene editing technology to the Regents of the University of California, the University of Vienna and Emmanuelle Charpentier covering use of guide...
11:09 AM, Jun 22, 2018  |  BC Week In Review | Company News  |  Other News

NIH ends funding for alcohol study

NIH said it will stop funding the Moderate Alcohol and Cardiovascular Health (MACH) study after concluding that NIH employees violated agency policies to secure its funding and potentially biased its design towards the alcohol industry. Led...
11:09 AM, Jun 22, 2018  |  BC Week In Review | Company News  |  Deals

Roche snaps up rest of Foundation to enhance global access

Roche (SIX:ROG; OTCQX:RHHBY) is acquiring the remaining shares of cancer diagnostics company Foundation Medicine Inc. (NASDAQ:FMI) that it does not already own for $137 per share in cash, or $2.4 billion. In 2015, Roche had acquired...
11:08 AM, Jun 22, 2018  |  BC Week In Review | Company News  |  Other News

Gawande to head Amazon-Berkshire-Chase healthcare company

Amazon.com Inc. (NASDAQ:AMZN), Berkshire Hathaway Inc. (NYSE:BRK.A; NYSE:BRK.B) and JPMorgan Chase & Co. (NYSE:JPM) hired Atul Gawande as CEO of their new company focused on U.S. employee healthcare, effective July 9. His experience draws from...
10:57 AM, Jun 22, 2018  |  BC Week In Review | Company News  |  Sales & Marketing

Vertex gets reimbursement deal for Orkambi in Sweden

Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) said June 18 it agreed to a long-term access agreement for cystic fibrosis drug Orkambi lumacaftor/ivacaftor with Swedish authorities. Beginning July 1, Orkambi will be reimbursed in Sweden at an undisclosed...
10:56 AM, Jun 22, 2018  |  BC Week In Review | Company News  |  Sales & Marketing

NICE recommends Roche's Ocrevus for relapse-remitting multiple sclerosis

The U.K.'s NICE issued a final appraisal determination (FAD) recommending the use of Ocrevus ocrelizumab from Roche (SIX:ROG; OTCQX:RHHBY) to treat relapse-remitting multiple sclerosis. In January, the European Commission approved the second-generation humanized mAb against CD20...

Pages